Peripheral Mononuclear Cell Rejuvenation for Senescence Surveillance in Alzheimer Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|9|1720-1726

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1720-1726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelets in Alzheimer's Disease-Associated Cellular Senescence and Inflammation

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1727-1738

Bentham Science Publishers

Access to resources Recommend Favorite

Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation

By  

Current Drug Targets, Vol. 16, Iss. 8, 2015-01 ,pp. : 780-785

Bentham Science Publishers

Access to resources Recommend Favorite

Memantine in Moderately-Severe-to-Severe Alzheimer's Disease: A Postmarketing Surveillance Study

By Clerici Francesca  

Drugs & Aging, Vol. 26, Iss. 4, 2009-05 ,pp. : 321-332

Adis International

Access to resources Recommend Favorite

Mechanisms of Cell Signaling and Inflammation in Alzheimer's Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 247-256

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Human Peripheral Blood Mononuclear Cell Proliferative Response by Diltiazem: In Vitro Comparison in Younger versus Older Subjects

By D'Ambrosio Antonella  

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 87-94

Adis International

Access to resources Recommend Favorite